Epidemiological studies suggest that estrogen therapy protects against clinical expression of chronic neurological diseases. These beneficial effects of estrogen therapy are highly modified by apolipoprotein E (apoE) through an unknown mechanism. We examined the short-term effects of estradiol replacement in ovariectomized mice on apoE expression and markers for cell proliferation, reactive gliosis, neuronal maturation, and synaptogenesis in the primary olfactory pathway of wild-type (WT) and apoE knockout (KO) mice. Three days of estradiol replacement increased apoE expression in the olfactory nerve and in the glomerular layer. Estradiol treatment also increased cell proliferation, total cell numbers, number of mature neurons in the olfact...
ApoE, a protein component of lipoproteins, is extensively expressed in the primary olfactory pathway...
Previous studies have shown that apoE is upregulated in injured nerves, and that it may participate ...
Alzheimer\u27s disease (AD) is a neurodegerative disorder characterized by progressive memory loss a...
Epidemiological studies suggest that estrogen therapy protects against clinical expression of chroni...
Olfactory dysfunction often precedes other clinical symptoms in chronic neurodegenerative diseases l...
Apolipoprotein E (apoE) is well studied for its role in cholesterol transportation and metabolizing ...
Previous studies have demonstrated that 17β-estradiol can modify apolipoprotein E (apoE) expression....
In recent years, there have been many studies looking at estrogen therapy (ET) as a treatment for Al...
Estrogen (E2) plasma levels fluctuate as a function of estrous cycling in the mouse. Apolipoprotein ...
Previous studies from our laboratory suggest that apolipoprotein (apoE), a lipid transporting protei...
Estrogen replacement therapy appears to delay the onset of Alzheimer\u27s disease (AD). The mechanis...
In this study we examined the role of apoE on the rate of synaptic recovery in the olfactory bulb (O...
The human apolipoprotein ε4 allele (APOE4) has been implicated as one of the strongest genetic risk ...
ApoE, a protein component of lipoproteins, is extensively expressed in the primary olfactory pathway...
Previous studies have shown that apoE is upregulated in injured nerves, and that it may participate ...
Alzheimer\u27s disease (AD) is a neurodegerative disorder characterized by progressive memory loss a...
Epidemiological studies suggest that estrogen therapy protects against clinical expression of chroni...
Olfactory dysfunction often precedes other clinical symptoms in chronic neurodegenerative diseases l...
Apolipoprotein E (apoE) is well studied for its role in cholesterol transportation and metabolizing ...
Previous studies have demonstrated that 17β-estradiol can modify apolipoprotein E (apoE) expression....
In recent years, there have been many studies looking at estrogen therapy (ET) as a treatment for Al...
Estrogen (E2) plasma levels fluctuate as a function of estrous cycling in the mouse. Apolipoprotein ...
Previous studies from our laboratory suggest that apolipoprotein (apoE), a lipid transporting protei...
Estrogen replacement therapy appears to delay the onset of Alzheimer\u27s disease (AD). The mechanis...
In this study we examined the role of apoE on the rate of synaptic recovery in the olfactory bulb (O...
The human apolipoprotein ε4 allele (APOE4) has been implicated as one of the strongest genetic risk ...
ApoE, a protein component of lipoproteins, is extensively expressed in the primary olfactory pathway...
Previous studies have shown that apoE is upregulated in injured nerves, and that it may participate ...
Alzheimer\u27s disease (AD) is a neurodegerative disorder characterized by progressive memory loss a...